Prophylaxis of perioperative blood loss

Orthopedics

Volumn 29, Issue 8, 2006, Pages 689-692

  Ramsey, E Zachary ^a   Smith, Kelly M ^b,c   Flynn, Jeremy D ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; APROTININ; CLOPIDOGREL; ENOXAPARIN; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; HEPARIN; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PHYTOMENADIONE; PROTAMINE SULFATE; RECOMBINANT ERYTHROPOIETIN; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; VITAMIN K GROUP; WARFARIN;

ANAPHYLAXIS; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; BRAIN DISEASE; CLINICAL TRIAL; COMORBIDITY; CRYOPRECIPITATE; DRUG COST; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG USE; ERYTHROCYTE TRANSFUSION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPOPROTHROMBINEMIA; IRON DEFICIENCY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PROTHROMBIN DEFICIENCY; SCREENING TEST; STROKE; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM;

EID: 33747788724     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20060801-13     Document Type: Article

References (11)

1. Tamir L, Fradin Z, Fridlander M, et al. Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery. Haematologia (Budap). 2001; 30:193-201.
2. Sculco TP. Blood management in orthopedic surgery. Am J Surg. 1995; 170:60S-63S.
3. Dagi TF. The management of postoperative bleeding. Surg Clin N Am. 2005: 85;1191-1213.
4. Coats T, Roberts I, Shakur H. Antifibrinolytic drugs for acute traumatic injury (Review). The Cochrane Database of Sytematic Reviews. 2004: 4. Article No: CD004896.pub2.DOI: 10.1002/14651858.CD004896. pub2.
5. Micromedex Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Micromedex.
6. Mosby Drug Consults 2006. Mosby Inc [Internet database]. Available at: www.mdconsult.com. Accessed April 3, 2006.
7. Goldberg MA. Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: pre-operative strategies for avoiding allogeneic blood exposure. Am J Surg. 1995; 170:37S-43S.
8. Henry DA, Moxey AJ, Carless PA, et al. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion (Review). The Cochrane Database of Systematic Reviews. 1999: 4. Article No: CD001886. DOI: 10.1002/14651858.CD001886.
9. Shiga T, Wajima Z, Inoue T, Sakamoto A. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials. Anesth Analg. 2005; 101:1602-1607.
10. Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006; 354:353-365.
11. Thompson G, Florentino-Pineda I, Poe-Kochert C. The role of Amicar in decreasing perioperative blood loss in idiopathic scoliosis. Spine. 2005; 30(17 suppl):S94-S99.